A Study to Evaluate the Safety and Efficacy of Bevacizumab in Combination With Chemotherapy in Previously Treated Metastatic Breast Cancer (RIBBON 2)

NCT00281697 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

684

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: Bevacizumab
DRUG: Placebo
DRUG: Standard chemotherapy

Sponsor

Genentech, Inc.